---
document_datetime: 2023-09-21 19:47:10
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/taxespira-previously-docetaxel-hospira-uk-limited-epar-all-authorised-presentations_en.pdf
document_name: taxespira-previously-docetaxel-hospira-uk-limited-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.05061
conversion_datetime: 2025-12-28 14:46:53.949199
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented)   | Strength   | Pharmaceutical Form                   | Route of        | Immediate    | Conte   | Pack size   |
|------------------|--------------|------------|---------------------------------------|-----------------|--------------|---------|-------------|
| EU/1/15/1017/001 | Taxespira    | 20 mg/1ml  | Concentrate for solution for infusion | Intravenous use | vial (glass) | 1 ml    | 1 vial      |
| EU/1/15/1017/002 | Taxespira    | 80 mg/4ml  | Concentrate for solution for infusion | Intravenous use | vial (glass) | 4 ml    | 1 vial      |
| EU/1/15/1017/003 | Taxespira    | 120 mg/6ml | Concentrate for solution for infusion | Intravenous use | vial (glass) | 6 ml    | 1 vial      |
| EU/1/15/1017/004 | Taxespira    | 140 mg/7ml | Concentrate for solution for infusion | Intravenous use | vial (glass) | 7 ml    | 1 vial      |
| EU/1/15/1017/005 | Taxespira    | 160 mg/8ml | Concentrate for solution for infusion | Intravenous use | vial (glass) | 8 ml    | 1 vial      |

<!-- image -->